Eye drops recalled nationwide due to labeling mix-up
AvKARE is recalling Polyvinyl Alcohol Ophthalmic Solution eye drops due to a labeling mix-up. The recall affects Lot #0160 and was distributed nationwide.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class III recall involving a labeling error (label mix-up). FDA Class III recalls are the least serious category. With no reported illnesses or injuries and only a labeling issue, this constitutes a minor labeling error corresponding to Score 2 (Moderate) per the severity rubric.
Plain-English summary
AvKARE is recalling Polyvinyl Alcohol Ophthalmic Solution 1.4% (moisturizing lubricant eye drops) in 0.5 FL OZ (15 mL) bottles due to a labeling mix-up. The recall affects product from Lot #0160 with an expiration date of April 26, 2026. The product was distributed nationwide throughout the United States.
The U.S. Food and Drug Administration classified this as a Class III recall, indicating the lowest severity category for drug recalls.
The recalled product
- Product
- POLYVINYL ALCOHOL (POLYVINYL ALCOHOL)
- Brand
- POLYVINYL ALCOHOL
- Manufacturer
- AvKARE
- Category
- Drug — Ophthalmic
- Hazard
- label-mix-up
- mis-labeling
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: 0160
- Exp. Date April 26 2026
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · POLYVINYL ALCOHOL
- HighPolyvinyl Alcohol Eye Drops Recalled for Sterility and Manufacturing Issues
FDA (Drugs) · 2025-05-14
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27